Page last updated: 2024-08-24

glucose, (beta-d)-isomer and becatecarin

glucose, (beta-d)-isomer has been researched along with becatecarin in 17 studies

Research

Studies (17)

TimeframeStudies, this research(%)All Research%
pre-19901 (5.88)18.7374
1990's1 (5.88)18.2507
2000's14 (82.35)29.6817
2010's1 (5.88)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dalterio, RA; Krishnan, BS; Lavoie, CP; Long, BH; Moore, ME; Rosenberg, IE; Wong, HS1
Dowlati, A; Gerson, SL; Hoppel, CL; Ingalls, ST; Ivy, P; Li, X; Majka, S; Remick, SC; Sedransk, N; Spiro, T1
Aylesworth, C; Campbell, E; Eckhardt, SG; Felton, S; Hammond, L; Hidalgo, M; Kuhn, J; Patnaik, A; Rizzo, J; Rowinsky, EK; Schwartz, G; Tolcher, AW; Weiss, G1
Alberti, D; Arzoomanian, R; Binger, K; Cleary, J; Dresen, A; Feierabend, C; Marnoccha, R; Merchant, J; Thomas, J; Tutsch, K; Wilding, G1
Forenza, S; Long, BH; Matson, JA; Rose, WC; Vyas, DM1
Baker, C; Goel, S; Hoffman, A; Ivy, P; Mani, S; Nazario, E; Silverman, A; Volterra, F; Wadler, S1
Baruchel, S; Bernstein, M; Blaney, S; Furman, W; Kuhn, JG; Langevin, AM; Vietti, T; Weintraub, ST; Weitman, SD1
Anizon, F; Bailly, C; Laine, W; Moreau, P; Prudhomme, M; Sancelme, M1
Flaherty, L; Heilbrun, LK; Hussain, M; Ivy, P; Jain, V; LoRusso, PM; Vaishampayan, U1
Rewcastle, GW1
Berg, K; Forero, L; Forouzesh, B; Goetz, A; Hammond, LA; Kuhn, JG; Ochoa-Bayona, JL; Ricart, AD; Rowinsky, EK; Takimoto, CH; Tolcher, AW1
Adamson, PC; Bernstein, M; Blaney, SM; Chen, Z; Ivy, P; Kuhn, JG; Langevin, AM; Sun, J1
Alvarado, Y; Borthakur, G; Bueso-Ramos, C; Cortes, J; Estrov, Z; Faderl, S; Giles, F; Ivy, P; Nebiyou Bekele, B; Ravandi-Kashani, F1
Ambudkar, SV; Bahr, JC; Bates, SE; Di Pietro, A; Macalou, S; Obrzut, T; Polgar, O; Robey, RW; Shukla, S1
Brell, J; Chak, A; Dowlati, A; Fu, P; Hoppel, CL; Ingalls, S; Ivy, P; Krishnamurthi, S; Posey, J; Ramanathan, RK; Rath, L; Remick, SC1
Bokar, JA; Brell, JM; Cooney, MM; Cooper, B; Dowlati, A; Gibbons, J; Ivy, P; Krishnamurthi, S; Manda, S; Nock, CJ; Remick, SC; Savvides, P1

Reviews

2 review(s) available for glucose, (beta-d)-isomer and becatecarin

ArticleYear
Discovery of antitumor indolocarbazoles: rebeccamycin, NSC 655649, and fluoroindolocarbazoles.
    Current medicinal chemistry. Anti-cancer agents, 2002, Volume: 2, Issue:2

    Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Antibiotics, Antineoplastic; Carbazoles; Drug Design; Glucosides; Humans; Indoles; Neoplasms; Structure-Activity Relationship

2002
Becatecarin (Helsinn Healthcare).
    IDrugs : the investigational drugs journal, 2005, Volume: 8, Issue:10

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carbazoles; Clinical Trials as Topic; DNA Topoisomerases, Type II; Fluorouracil; Glucosides; Humans; Indoles; Leucovorin; Randomized Controlled Trials as Topic; Survival; Topoisomerase II Inhibitors

2005

Trials

11 trial(s) available for glucose, (beta-d)-isomer and becatecarin

ArticleYear
Phase I clinical and pharmacokinetic study of rebeccamycin analog NSC 655649 given daily for five consecutive days.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Apr-15, Volume: 19, Issue:8

    Topics: Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Antineoplastic Agents; Carbazoles; Cholangiocarcinoma; Disease Progression; Dose-Response Relationship, Drug; Female; Gallbladder Neoplasms; Glucosides; Humans; Infusions, Intravenous; Liver Neoplasms; Male; Middle Aged; Neoplasms; Neutropenia

2001
Phase I and pharmacokinetic study of NSC 655649, a rebeccamycin analog with topoisomerase inhibitory properties.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Jun-01, Volume: 19, Issue:11

    Topics: Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Antineoplastic Agents; Carbazoles; Dose-Response Relationship, Drug; Female; Glucosides; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasms; Neutropenia; Thrombocytopenia

2001
Phase I clinical and pharmacokinetic study of NSC 655649, a rebeccamycin analogue, given in both single-dose and multiple-dose formats.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2002, Volume: 8, Issue:7

    Topics: Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Antineoplastic Agents; Carbazoles; Dose-Response Relationship, Drug; Female; Gastrointestinal Diseases; Glucosides; Humans; Infusions, Intravenous; Male; Maximum Tolerated Dose; Middle Aged; Neoplasms; Neutropenia; Thrombocytopenia

2002
A phase II study of rebeccamycin analog NSC 655649 in patients with metastatic colorectal cancer.
    Investigational new drugs, 2003, Volume: 21, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Aminoglycosides; Antineoplastic Agents; Carbazoles; Colorectal Neoplasms; Drug Administration Schedule; Female; Glucosides; Humans; Injections, Intravenous; Male; Middle Aged; Neoplasm Metastasis; Treatment Outcome

2003
Phase I trial of rebeccamycin analog (NSC #655649) in children with refractory solid tumors: a pediatric oncology group study.
    Journal of pediatric hematology/oncology, 2003, Volume: 25, Issue:7

    Topics: Adolescent; Aminoglycosides; Anti-Bacterial Agents; Antibiotics, Antineoplastic; Area Under Curve; Carbazoles; Child; Child, Preschool; Drug Administration Schedule; Glucosides; Hemoglobins; Humans; Infant; Metabolic Clearance Rate; Neoplasms; Neutropenia; Patient Selection; Platelet Count

2003
A phase II study of rebeccamycin analog (NSC-655649) in metastatic renal cell cancer.
    Investigational new drugs, 2003, Volume: 21, Issue:4

    Topics: Adult; Aged; Aminoglycosides; Carbazoles; Carcinoma, Renal Cell; Confidence Intervals; Female; Glucosides; Humans; Indoles; Kidney Neoplasms; Male; Middle Aged; Survival Rate

2003
Phase I and pharmacokinetic study of sequences of the rebeccamycin analogue NSC 655649 and cisplatin in patients with advanced solid tumors.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2005, Dec-15, Volume: 11, Issue:24 Pt 1

    Topics: Adult; Aged; Aged, 80 and over; Aminoglycosides; Antineoplastic Combined Chemotherapy Protocols; Carbazoles; Cisplatin; Drug Interactions; Female; Glucosides; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Thrombocytopenia; Tomography, X-Ray Computed

2005
A phase II trial of rebeccamycin analogue (NSC #655649) in children with solid tumors: a Children's Oncology Group study.
    Pediatric blood & cancer, 2008, Volume: 50, Issue:3

    Topics: Adolescent; Adult; Aminoglycosides; Antibiotics, Antineoplastic; Bone Marrow Diseases; Carbazoles; Central Nervous System Neoplasms; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Female; Glucosides; Humans; Infant; Infant, Newborn; Infusions, Intravenous; Male; Neoplasm Proteins; Neoplasms; Pancreatitis; Rhabdomyosarcoma; Salvage Therapy; Topoisomerase II Inhibitors

2008
Phase 1 study of XL119, a rebeccamycin analog, in patients with refractory hematologic malignancies.
    Cancer, 2008, Jul-15, Volume: 113, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Bacterial Infections; Biopsy; Bone Marrow; Carbazoles; Dose-Response Relationship, Drug; Female; Glucosides; Hematologic Neoplasms; Humans; Male; Middle Aged; Virus Diseases

2008
Phase II and pharmacokinetic trial of rebeccamycin analog in advanced biliary cancers.
    Cancer chemotherapy and pharmacology, 2009, Volume: 65, Issue:1

    Topics: Aged; Antineoplastic Agents; Bile Duct Neoplasms; CA-19-9 Antigen; Carbazoles; Female; Fever; Gallbladder Neoplasms; Glucosides; Humans; Male; Middle Aged; Neutropenia; Survival Rate; Thrombocytopenia

2009
A phase I study of rebeccamycin analog in combination with oxaliplatin in patients with refractory solid tumors.
    Investigational new drugs, 2011, Volume: 29, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carbazoles; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Female; Glucosides; Humans; Male; Middle Aged; Neoplasms; Organoplatinum Compounds; Oxaliplatin

2011

Other Studies

4 other study(ies) available for glucose, (beta-d)-isomer and becatecarin

ArticleYear
Fluorescence polarization studies of the binding of BMS 181176 to DNA.
    Journal of biomolecular structure & dynamics, 1994, Volume: 12, Issue:3

    Topics: Acridine Orange; Animals; Antibiotics, Antineoplastic; Binding, Competitive; Carbazoles; Cattle; DNA; DNA, Bacterial; DNA, Superhelical; Doxorubicin; Ethidium; Fluorescence Polarization; Glucosides; Indoles; Intercalating Agents; Male; Micrococcus; Nucleic Acid Conformation; Plasmids; Poly dA-dT; Salmon; Spermatozoa; Thymus Gland

1994
Rebeccamycin analogues bearing amine substituents or other groups on the sugar moiety.
    Bioorganic & medicinal chemistry, 2003, Aug-15, Volume: 11, Issue:17

    Topics: Amines; Aminoglycosides; Animals; Anti-Bacterial Agents; Antineoplastic Agents; Carbazoles; Deoxyribonucleases; Glucose; Glucosides; Glycosylation; Humans; Indoles; Structure-Activity Relationship; Topoisomerase II Inhibitors

2003
REBECCA Parrish, M.D.; founder of the Mary Jonston Hospital Manila, Philippine Islands.
    Journal of the American Medical Women's Association, 1951, Volume: 6, Issue:8

    Topics: Carbazoles; Glucosides; Haptophyta; Humans; Islands; Philippines

1951
Becatecarin (rebeccamycin analog, NSC 655649) is a transport substrate and induces expression of the ATP-binding cassette transporter, ABCG2, in lung carcinoma cells.
    Cancer chemotherapy and pharmacology, 2009, Volume: 64, Issue:3

    Topics: Adenosine Triphosphatases; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Azides; Biological Transport; Carbazoles; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Flow Cytometry; Fluorescence; Gene Expression Regulation, Neoplastic; Glucosides; Humans; Immunoblotting; Iodine Radioisotopes; Lung Neoplasms; Neoplasm Proteins; Prazosin

2009
chemdatabank.com